COFINIMMO

Cofinimmo reports an EPRA result of €62m for Q1 (+8.3%) and earnings per share of €1.63 (including -€0.12 from disposals). The company confirms its full-year guidance of €6.35 EPRA per share. Occupancy stood at 98.5% at the end of March (healthcare properties 99.4%, distribution networks 99.8%, office properties 93.5%), like-for-like rental growth slowed to 1.1% and office space showed a decline. EPRA NTA rose to €93.98 (+1.1%), the debt ratio fell to 42.1% and Cofinimmo plans net investments of €200m for 2026. » Más en de.investing.com

Cofinimmo reports an EPRA result of €246m for Q4 2025 (+0.7%) and an EPRA result per share of €6.45, thereby beating expectations. The portfolio remains robust, with 77% of portfolio value in healthcare properties and a fair value of €6.1bn. Gross rental income rose by 2.9% on a like‑for‑like basis, the debt ratio stayed stable at 42.8%, and the dividend for 2025 was confirmed at €5.20 per share. Cofinimmo expects further growth in the healthcare segment but cites risks from interest rate fluctuations, macroeconomic volatility and regulatory changes in Europe. » Más en de.investing.com

Cofinimmo reports an H1 2025 net result attributable to shareholders of €112m and a net result from core activities of €122m, both above its own forecasts. Healthcare properties account for 77% of the €6bn portfolio and drive like‑for‑like rental growth of almost 3%; the occupancy rate is 98.6% with an average remaining lease term of 13 years. Management confirms the annual guidance (EPRA earnings per share ≥ €6.20; gross dividend €5.20) and points to a loan‑to‑value of 44.4%, very low cost of debt (1.4%) and available credit lines of €866m. The strategic shift toward healthcare properties, geographic diversification and the review of a possible merger with Aedifica are in focus, while 56% of the 2025 disposal target has already been achieved. » Más en de.investing.com